| Danielle Farr, MS CCC-SLP | |
|
519 Ivy Pl, Brick, NJ 08724-4615 | |
| (732) 773-5270 | |
| Not Available |
| Full Name | Danielle Farr |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 519 Ivy Pl, Brick, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457730640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 41YS00657100 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Farr, MS CCC-SLP 519 Ivy Pl, Brick, NJ 08724-4615 Ph: (732) 773-5270 | Danielle Farr, MS CCC-SLP 519 Ivy Pl, Brick, NJ 08724-4615 Ph: (732) 773-5270 |
News Archive
Researchers at the Ontario Institute for Cancer Research and the University Health Network have discovered detailed new information about the subtypes of pancreatic cancer. A better understanding of the disease groups may lead to new treatment options and improved clinical outcomes for this lethal disease.
QIAGEN N.V. today announced the commercial launch in India of its careHPV™ Test, the only molecular diagnostic for high-risk human papillomavirus (HPV) designed to screen women in settings with limited healthcare infrastructure, such as areas lacking electricity, water or laboratories.
With the COVID-19 pandemic continuing to spread across the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.
The present estimate of UV exposure, the UV index, is based on measuring how much radiation hits a horizontal surface. But this often underestimates how much UV hits a vertical surface when the sun is low in the sky, says Peter Hoeppe, a biometeorologist at Geo Risk Research in Munich, Germany.
Amgen today announced a decision to stop the ganitumab (AMG 479) Phase 3 GAMMA (Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas) trial following the recommendation of an independent Data Monitoring Committee (DMC) overseeing the trial.
› Verified 9 days ago
Christine Schuler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 | |
Ms. Lauren Maureen Kropa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 793 Troy Ct, Brick, NJ 08724 Phone: 732-903-4117 | |
Jeanne Quinn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 Fax: 732-701-3709 | |
Ms. Aubree Nicole Nachman, MA CCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1683 Route 88, Brick, NJ 08724 Phone: 732-840-5266 | |
Mrs. Julie Ann Ferwerda, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 69 Pacific Ocean Dr, Brick, NJ 08723 Phone: 732-262-1698 | |
Emily Kosch, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 Fax: 732-701-3709 | |
Dawn Dougherty, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2557 Hooper Ave, Brick, NJ 08723 Phone: 732-701-3711 Fax: 732-701-3709 |